99 results
Page 3 of 5
8-K
EX-10.1
epmbc4ibfdwe vm
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
6ybpez8gnwhlj9xubhj2
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
8-K
EX-10.1
sb5h73nvy2iin
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
8-K
EX-1.1
ij64qz
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
424B4
eyf4w bk1tku
5 Oct 20
Prospectus supplement with pricing info
4:16pm
8-K
EX-10.1
1ecmuv9nz6irg0cj39
27 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
pubk546zb5qc435w263d
20 Aug 20
Entry into a Material Definitive Agreement
9:30am